T cell fat catabolism: A novel target for kynurenine?

Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward

(2021) Maria Rain Jennings et al.   Journal for ImmunoTherapy of Cancer

Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo

(2021) Peter J. Siska et al.   EBioMedicine

Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth

(2016) Yanling Liu et al.   Oncotarget

Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy

(2015) L. Zhai et al.   CLINICAL CANCER RESEARCH

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

(2014) Alban Bessede et al.   NATURE

Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22

(2013) Teresa Zelante et al.   IMMUNITY

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

(2011) Maria T Pallotta et al.   NATURE IMMUNOLOGY